These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35778780)

  • 1. Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.
    Diver S; Haldar K; McDowell PJ; Busby J; Mistry V; Micieli C; Brown V; Cox C; Yang F; Borg C; Shrimanker R; Ramsheh MY; Hardman T; Arron J; Bradding P; Cowan D; Mansur AH; Fowler SJ; Lordan J; Menzies-Gow A; Robinson D; Matthews J; Pavord ID; Chaudhuri R; Heaney LG; Barer MR; Brightling C;
    Allergy; 2022 Nov; 77(11):3362-3376. PubMed ID: 35778780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway Microbiome Composition and Co-Occurrence Network Are Associated with Inflammatory Phenotypes of Asthma.
    Li Y; Zou C; Li J; Wang W; Wang F; Guo Y
    Int Arch Allergy Immunol; 2023; 184(12):1254-1263. PubMed ID: 37690443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The airway microbiome in patients with severe asthma: Associations with disease features and severity.
    Huang YJ; Nariya S; Harris JM; Lynch SV; Choy DF; Arron JR; Boushey H
    J Allergy Clin Immunol; 2015 Oct; 136(4):874-84. PubMed ID: 26220531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome.
    Sverrild A; Kiilerich P; Brejnrod A; Pedersen R; Porsbjerg C; Bergqvist A; Erjefält JS; Kristiansen K; Backer V
    J Allergy Clin Immunol; 2017 Aug; 140(2):407-417.e11. PubMed ID: 28042058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophilic Asthma Is Associated with Increased Airway Bacterial Burden and Disordered Community Composition.
    Yang X; Li H; Ma Q; Zhang Q; Wang C
    Biomed Res Int; 2018; 2018():9230234. PubMed ID: 30105264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts.
    Hoshino Y; Soma T; Uchida Y; Shiko Y; Nakagome K; Nagata M
    Front Pharmacol; 2022; 13():836635. PubMed ID: 35517829
    [No Abstract]   [Full Text] [Related]  

  • 7. Increase in FeNO Levels Following IL5/IL5R-Targeting Therapies in Severe Asthma: A Case Series.
    Pelletier G; Godbout K; Boulay MÈ; Boulet LP; Morissette MC; Côté A
    J Asthma Allergy; 2022; 15():691-701. PubMed ID: 35615256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).
    Petsky HL; Cates CJ; Lasserson TJ; Li AM; Turner C; Kynaston JA; Chang AB
    Thorax; 2012 Mar; 67(3):199-208. PubMed ID: 20937641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
    Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
    J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma.
    Soma T; Iemura H; Naito E; Miyauchi S; Uchida Y; Nakagome K; Nagata M
    Allergol Int; 2018 Sep; 67S():S3-S11. PubMed ID: 29754974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils.
    Walsh CJ; Zaihra T; Benedetti A; Fugère C; Olivenstein R; Lemière C; Hamid Q; Martin JG
    Clin Exp Allergy; 2016 Oct; 46(10):1291-302. PubMed ID: 27214328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma-associated differences in microbial composition of induced sputum.
    Marri PR; Stern DA; Wright AL; Billheimer D; Martinez FD
    J Allergy Clin Immunol; 2013 Feb; 131(2):346-52.e1-3. PubMed ID: 23265859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
    Nair P; Pizzichini MM; Kjarsgaard M; Inman MD; Efthimiadis A; Pizzichini E; Hargreave FE; O'Byrne PM
    N Engl J Med; 2009 Mar; 360(10):985-93. PubMed ID: 19264687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
    Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
    J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus-predominant subgroup.
    Diver S; Richardson M; Haldar K; Ghebre MA; Ramsheh MY; Bafadhel M; Desai D; Cohen ES; Newbold P; Rapley L; Rugman P; Pavord ID; May RD; Barer M; Brightling CE
    Allergy; 2020 Apr; 75(4):808-817. PubMed ID: 31556120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper and lower airway inflammation in severe asthmatics: a guide for a precision biologic treatment.
    Latorre M; Bacci E; Seccia V; Bartoli ML; Cardini C; Cianchetti S; Cristofani L; Di Franco A; Miccoli M; Puxeddu I; Celi A; Paggiaro P
    Ther Adv Respir Dis; 2020; 14():1753466620965151. PubMed ID: 33263506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis.
    Busse WW; Wenzel SE; Casale TB; FitzGerald JM; Rice MS; Daizadeh N; Deniz Y; Patel N; Harel S; Rowe PJ; Graham NMH; O'Riordan T; Pavord ID
    Lancet Respir Med; 2021 Oct; 9(10):1165-1173. PubMed ID: 34181876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma.
    Buhl R; Korn S; Menzies-Gow A; Aubier M; Chapman KR; Canonica GW; Picado C; Donica M; Kuhlbusch K; Korom S; Hanania NA
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2630-2639.e6. PubMed ID: 32304841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2-high asthma is associated with a specific indoor mycobiome and microbiome.
    Vandenborght LE; Enaud R; Urien C; Coron N; Girodet PO; Ferreira S; Berger P; Delhaes L
    J Allergy Clin Immunol; 2021 Apr; 147(4):1296-1305.e6. PubMed ID: 32926879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct associations of sputum and oral microbiota with atopic, immunologic, and clinical features in mild asthma.
    Durack J; Christian LS; Nariya S; Gonzalez J; Bhakta NR; Ansel KM; Beigelman A; Castro M; Dyer AM; Israel E; Kraft M; Martin RJ; Mauger DT; Peters SP; Rosenberg SR; Sorkness CA; Wechsler ME; Wenzel SE; White SR; Lynch SV; Boushey HA; Huang YJ;
    J Allergy Clin Immunol; 2020 Nov; 146(5):1016-1026. PubMed ID: 32298699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.